Limited hours at AHRA upset PACS companiesInterest in PACS technology was high at last month's American Healthcare Radiology Administrators meeting in Minneapolis, but you had to move quickly to cover the entire show, due to the limited hours of
Interest in PACS technology was high at last month's American Healthcare Radiology Administrators meeting in Minneapolis, but you had to move quickly to cover the entire show, due to the limited hours of the technical exhibition. The exhibit was open only 11 hours during the four-day span of the meeting, a schedule that upset many vendors.
On the technology side, over two dozen PACS vendors showed their products and services. Partnerships were heavily promoted: Cemax-Icon and OEM partner Picker International actively pitched the Cemax-Icon product line, while Data General touted its agreement with MarkCare.
Shared Medical Systems pushed its Integrated Multimedia Solutions PACS product line, while Imnet Systems, Dynamic Healthcare Technologies, and others showed the integrated PACS/information systems concept as well. Conspicuously absent were PACS firms Eastman Kodak, EMED, CompuRad, and Olicon, although some of these vendors provided financial support. GE and Siemens chose to exhibit with low profiles.
Among interesting new developments were Canon/AOP Medical's announcement that their compact 100-sheet charge-coupled device film scanner is now deliverable, and that they are targeting a launch date of January 1998 for their digital radiography detector. In addition, Articulate Systems/MRC Group showed an integrated network-based dictation/voice recognition system.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.